Jacobs Levy Equity Management, Inc Merrimack Pharmaceuticals Inc Transaction History

Jacobs Levy Equity Management, Inc

$24.7 Billion
Q3 2024

Shares

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2020 May 15, 2020	SELL	$1.63 - $3.58 $68,958 - $151,455	-42,306 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.16 - $6.05 $32,726 - $47,595	7,867 Added 22.84%	42,306 $190,000
Q2 2019 Aug 13, 2019	BUY	$4.39 - $5.66 $44,510 - $57,386	10,139 Added 41.72%	34,439 $208,000
Q1 2019 May 14, 2019	SELL	$3.19 - $5.73 $57,116 - $102,595	-17,905 Reduced 42.42%	24,300 $169,000
Q3 2018 Nov 14, 2018	BUY	$3.91 - $4.66 $17,204 - $20,504	4,400 Added 11.64%	42,205 $225,000
Q2 2018 Aug 14, 2018	SELL	$3.86 - $7.61 $32,424 - $63,924	-8,400 Reduced 18.18%	37,805 $186,000
Q1 2018 May 15, 2018	BUY	$6.24 - $9.15 $161,023 - $236,115	25,805 Added 126.5%	46,205 $372,000
Q4 2017 Feb 13, 2018	BUY	$7.99 - $11.87 $54,332 - $80,716	6,800 Added 50.0%	20,400 $209,000
Q3 2017 Nov 14, 2017	BUY	$9.13 - $11.72 $124,168 - $159,392	13,600	13,600 $198,000

Others Institutions Holding MACK

# of Institutions

1

Shares Held

77

Call Options Held

0

Put Options Held

0

Farther Finance Advisors, LLC San Francisco, CA

77
Shares

$1,165
0.0% of portfolio

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.